Combination treatment for nonhematologic malignancies using an anti-igf-1r antibody

Details for Australian Patent Application No. 2005264063 (hide)

International Classifications

Event Publications

25 January 2007 PCT application entered the National Phase

PCT publication WO2006/008639 Priority application(s): WO2006/008639

10 September 2009 Application Accepted

Published as AU-B-2005264063

24 December 2009 Opposition Lodged

Amgen Inc. has lodged an opposition against Pfizer Products Inc.

25 March 2010 Opposition Withdrawn

The opposition by Amgen Inc. against Pfizer Products Inc has been withdrawn.

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.